Sixth Street Partners Management Company »

Lyell Immunopharma shares owned by Sixth Street Partners Management Company

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Sixth Street Partners Management Company from 13F filings

Historical chart of Sixth Street Partners Management Company investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Sixth Street Partners Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Sixth Street Partners Management Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.5M 108k 14.05

More positions owned by Sixth Street Partners Management Company

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Micron Technology (MU)
Schwab Strategic Tr Fundamental Intl (FNDF)
Eli Lilly & Co. (LLY)
Home Depot (HD)

View all positions for Sixth Street Partners Management Company

Top funds holding Lyell Immunopharma

Arch Venture Corp
GSK
Vanguard Capital Management
Orland Properties
BlackRock
Almitas Capital
Foresite Capital Management V
Millennium Management
Opaleye Management
venBio Partners
Geode Capital Management
Alphabet
Sc China Holding
Renaissance Technologies
Northern Trust

View all funds holding Lyell Immunopharma